The role of hematopoietic cell transplantation (HCT) in the therapy of Hodgkin lymphoma
(HL) in pediatric and adult patients is reviewed and critically evaluated in this systematic …

Despite the generally excellent prognosis of children and adolescents with Hodgkin's
lymphoma (HL), approximately 15% of patients relapse. Salvage therapy options include …

Allogeneic stem cell transplantation (allo-SCT) outcomes in patients with Hodgkin
lymphoma (HL) remain poorly defined. We performed a meta-analysis of allo-SCT studies in …

The purpose of this study is to evaluate the survival of pediatric patients undergoing
autologous bone marrow transplantation (auBMT) for relapsed or refractory Hodgkin …

For patients with relapsed Hodgkin's lymphoma (HL), high dose chemotherapy with stem
cell rescue (HDCT-SCT) may improve survival over chemotherapy alone. We assessed the …

Hodgkin lymphoma is one of the few cancers that affect both adults and children. Cure rates
for Hodgkin lymphoma remain among the best for pediatric cancers. However, cure is often …

ASCT results might well be implemented by improving the quality of the remission of patients
undergoing the procedure with more effective salvage protocols or by selecting those …

Ninety-one children and adolescents 18 years or younger after allogeneic hematopoietic
stem cell transplantation (HSCT) for relapsed or refractory Hodgkin lymphoma (HL) were …

PURPOSE We analyzed the outcome of autologous bone marrow transplantation (ABMT) in
pediatric and adult patients with Hodgkin's disease (HD) by means of a case-controlled …

GISL recently conducted an exhaustive survey of 1078 patients with Hodgkin's Lymphoma
(HL) enrolled between 1988 and 2002 in different prospective trials. Treatment failure was …